Karen Rands is joind by David Feldman to discuss the history and outcome of Reg A+ since its inception in 2016. They will explore the good and bad of almost 125 deals, averaging $10 million per deal, since inception. Just 10 of the issuers got listed on Nasdaq or the NYSE, though unfortunately their stocks have not fared well generally. Most of them were, for all practical purposes, start ups. The NYSE recently decided to pause taking new Reg A+ issuers, and the Nasdaq lately had been slow walking them. This proposed requirement to be operating two years to get a Nasdaq listing makes sense.
David is a partner at Duane Morris LLP, and focuses on corporate, securities and financing matters for public and private companies, investment banks, private equity firms and high-net worth individuals. He is considered a leading authority on alternatives to traditional initial public offerings, including the new Regulation A+. He published a book on that subject, called Regulation A+ and Other Alternatives to a Traditional IPO (John Wiley & Sons), in 2018. This is his 4th time as a guest on the Compassionate Capitalist Podcast. https://www.duanemorris.com/attorneys/davidnfeldman.html
Karen Rands is the best selling author of Inside Secets to Angel Investing. It is primer for investors to understand the risks and rewards of investing in private company stock. Savvy investors that invest public stock, looking for those with the most upside potential, use her book to understand how they can invest in Reg A+ companies as a future potential public stock. She helps companies determine their strategy for raising capital and execute on the strategy. https://karenrands.co